Skip to main content
. 2022 Nov 10;13:1039020. doi: 10.3389/fimmu.2022.1039020

Table 5.

Differences in the incidence of AEs with ESCC vs EAC groups.

ESCC Incidence (%) (95%CI) EAC (at least 70%) Incidence (%) (95%CI) p value
All-grade AEs 92.96 (61.56-99.09) 83.31 (66.21-92.71) 0.41
Esophagitis 49.68 (33.46-65.97) 60.00 (44.35-73.85) 0.38
Fatigue 25.16 (10.22-49.83) 51.80 (9.65-91.54) 0.37
Hypothyroidism 22.55 (9.34-45.15) 8.96 (6.88-11.60) 0.049
Elevated AST 20.26 (10.22-36.19) 8.84 (4.53-16.53) 0.08
Skin rash 15.25 (8.13-26.79) 9.52 (7.43-12.12) 0.17
Elevated ALT 14.19 (6.89-26.98) 14.29 (8.09-23.99) 0.99
Pneumonitis 12.89 (7.70-20.80) 2.70 (0.38-16.85) 0.11
Anorexia 12.23 (0.95-66.87) 42.50 (28.31-58.04) 0.23
Nausea 10.05 (2.70-31.04) 20.94 (7.39-46.76) 0.36
Pruritus 9.09 (2.28-29.96) 10.37 (8.12-13.15) 0.85
Hyperthyroidism 8.93 (3.77-19.72) 6.68 (4.90-9.05) 0.53
Arthralgia 4.44 (1.11-16.11) 8.01 (3.57-16.96) 0.46
Diarrhea 1.12 (0.02-34.05) 17.24 (14.44-20.45) 0.14
High-grade AEs 14.41 (4.62-36.91) 24.75 (13.43-41.09) 0.37
Leukopenia 6.25 (2.83-13.22) 59.09 (38.17-77.16) 0.00
Elevated AST 2.38 (0.33-15.06) 0.99 (0.12-7.64) 0.55
Fatigue 1.68 (0.42-6.47) 0.12 (0.00-7.80) 0.24
Elevated ALT 1.61 (0.23-10.57) 1.30 (0.18-8.64) 0.88
Grade 5 AEs 0.98 (0.25-3.83) 0.10 (0.00-6.72) 0.33
Pneumonitis 0.64 (0.09-4.41) 0.88 (0.37-2.09) 0.77

The bold values mean that there are significant statistical differences in subgroup analysis of these AEs.